Moreover, a recent study examining the effect of LATS1/2 deletion in colon cancer cell growth showed an inhibition of cell proliferation in vitro and tumor growth in vivo, together with a selective induction of WISP2 gene expression [53]. The gene discussed is CCN5; the disease is neoplasm.